sertraline has been researched along with Vascular Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barch, DM; Doraiswamy, PM; DʼAngelo, G; Garcia, KS; Gersing, K; Pieper, C; Sheline, YI; Taylor, W; Welsh-Bohmer, K; Wilkins, CH | 1 |
Clary, CM; Doraiswamy, PM; Krishnan, KR | 1 |
2 trial(s) available for sertraline and Vascular Diseases
Article | Year |
---|---|
Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset.
Topics: Age of Onset; Aged; Antidepressive Agents; Cognition Disorders; Depression; Executive Function; Female; Humans; Male; Memory; Mental Status Schedule; Sertraline; Severity of Illness Index; Treatment Outcome; Vascular Diseases | 2012 |
Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline.
Topics: Age of Onset; Aged; Antidepressive Agents; Anxiety; Cardiovascular Diseases; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Hypertension; Male; Mental Status Schedule; Middle Aged; Nortriptyline; Patient Selection; Placebos; Psychiatric Status Rating Scales; Safety; Sertraline; Vascular Diseases | 2001 |